Theranexus Aktie
| 1,01EUR | -0,06EUR | -5,16% |
WKN DE: A2H6LX / ISIN: FR0013286259
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 17 | 19 | 21 | 0 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 14 | 15 | 11 | 6 | 3 |
| Summe Anlagevermögen | 3 | 2 | 2 | 1 | 1 |
| Summe Aktiva | 17 | 17 | 12 | 7 | 4 |
Bilanz (in Mio. EUR) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 9 | 8 | 9 | 8 | 6 |
| Summe Eigenkapital | 9 | 9 | 3 | -1 | -2 |
| Summe Passiva | 17 | 17 | 12 | 7 | 4 |
Adresse
| Pepiniere Laennec, 69008 Lyon | |
| Telefon | +33 (1) 53-67-36-75 |
| Internet | http://www.theranexus.com |
Management
|
Christine Placet
Director-Finance & Administration |
|
Eric Doulat
Independent Director |
|
Franck Joseph Mouthon
Non-Executive Director |
|
Francoise Vincent-Larrode
Director-Human Resources |
|
Julien Veys
Chief Operating & Business Development Officer |
|
Jérôme Martinez
Independent Director |
|
Marie Sebille
Chief Medical Officer |
|
Mathieu Bernard Mari Charveriat
Chairman & Chief Executive Officer |
|
Rodolphe Besserve
Independent Director |
|
Thierry Bertrand Lambert
Investor Relations Contact |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.